N-(2-cyclohexyl-6-methoxyindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;N-(2-cyclohexyl-6-methoxy-3-methylindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;methane;N-[6-methoxy-3-methyl-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

C109H117F15N22O10 — CID 159082886

IUPACN-(2-cyclohexyl-6-methoxyindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;N-(2-cyclohexyl-6-methoxy-3-methylindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;methane;N-[6-methoxy-3-methyl-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESC.COc1cc2nn(C3CCCCC3)c(C)c2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCCCC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCN(C)CC3)c(C)c2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCN(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)c1.COc1cc2nn(C3CCN(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1
InChIInChI=1S/C22H24F3N5O2.2C22H23F3N4O2.C21H22F3N5O2.C21H21F3N4O2.CH4/c1-13-15-11-18(27-21(31)16-5-4-6-20(26-16)22(23,24)25)19(32-3)12-17(15)28-30(13)14-7-9-29(2)10-8-14;1-28-8-6-17(7-9-28)29-13-15-11-19(20(31-2)12-18(15)27-29)26-21(30)14-4-3-5-16(10-14)22(23,24)25;1-13-15-11-18(27-21(30)16-9-6-10-20(26-16)22(23,24)25)19(31-2)12-17(15)28-29(13)14-7-4-3-5-8-14;1-28-8-6-14(7-9-28)29-12-13-10-17(18(31-2)11-16(13)27-29)26-20(30)15-4-3-5-19(25-15)21(22,23)24;1-30-18-11-16-13(12-28(27-16)14-6-3-2-4-7-14)10-17(18)26-20(29)15-8-5-9-19(25-15)21(22,23)24;/h4-6,11-12,14H,7-10H2,1-3H3,(H,27,31);3-5,10-13,17H,6-9H2,1-2H3,(H,26,30);6,9-12,14H,3-5,7-8H2,1-2H3,(H,27,30);3-5,10-12,14H,6-9H2,1-2H3,(H,26,30);5,8-12,14H,2-4,6-7H2,1H3,(H,26,29);1H4
InChIKeyKBBPXUYLZLEAGT-UHFFFAOYSA-N
MW2180.25 g/mol
LogP24.22
Rot. Bonds20

About N-(2-cyclohexyl-6-methoxyindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;N-(2-cyclohexyl-6-methoxy-3-methylindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;methane;N-[6-methoxy-3-methyl-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

N-(2-cyclohexyl-6-methoxyindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;N-(2-cyclohexyl-6-methoxy-3-methylindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;methane;N-[6-methoxy-3-methyl-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (PubChem CID 159082886) has the molecular formula C109H117F15N22O10 and a molecular weight of 2180.25 g/mol. Its IUPAC name is N-(2-cyclohexyl-6-methoxyindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;N-(2-cyclohexyl-6-methoxy-3-methylindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;methane;N-[6-methoxy-3-methyl-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.

Molecular Properties

Compound NameN-(2-cyclohexyl-6-methoxyindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;N-(2-cyclohexyl-6-methoxy-3-methylindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;methane;N-[6-methoxy-3-methyl-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
PubChem CID159082886
Molecular FormulaC109H117F15N22O10
Molecular Weight2180.25 g/mol
Exact Mass2178.91
IUPAC NameN-(2-cyclohexyl-6-methoxyindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;N-(2-cyclohexyl-6-methoxy-3-methylindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;methane;N-[6-methoxy-3-methyl-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESC.COc1cc2nn(C3CCCCC3)c(C)c2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCCCC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCN(C)CC3)c(C)c2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCN(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)c1.COc1cc2nn(C3CCN(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1
InChIInChI=1S/C22H24F3N5O2.2C22H23F3N4O2.C21H22F3N5O2.C21H21F3N4O2.CH4/c1-13-15-11-18(27-21(31)16-5-4-6-20(26-16)22(23,24)25)19(32-3)12-17(15)28-30(13)14-7-9-29(2)10-8-14;1-28-8-6-17(7-9-28)29-13-15-11-19(20(31-2)12-18(15)27-29)26-21(30)14-4-3-5-16(10-14)22(23,24)25;1-13-15-11-18(27-21(30)16-9-6-10-20(26-16)22(23,24)25)19(31-2)12-17(15)28-29(13)14-7-4-3-5-8-14;1-28-8-6-14(7-9-28)29-12-13-10-17(18(31-2)11-16(13)27-29)26-20(30)15-4-3-5-19(25-15)21(22,23)24;1-30-18-11-16-13(12-28(27-16)14-6-3-2-4-7-14)10-17(18)26-20(29)15-8-5-9-19(25-15)21(22,23)24;/h4-6,11-12,14H,7-10H2,1-3H3,(H,27,31);3-5,10-13,17H,6-9H2,1-2H3,(H,26,30);6,9-12,14H,3-5,7-8H2,1-2H3,(H,27,30);3-5,10-12,14H,6-9H2,1-2H3,(H,26,30);5,8-12,14H,2-4,6-7H2,1H3,(H,26,29);1H4
InChIKeyKBBPXUYLZLEAGT-UHFFFAOYSA-N
XLogP24.22
TPSA342.03 Ų
H-Bond Donors5
H-Bond Acceptors27
Rotatable Bonds20
Heavy Atoms156
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002180.25
LogP ≤ 524.22
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1027

Analyze N-(2-cyclohexyl-6-methoxyindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;N-(2-cyclohexyl-6-methoxy-3-methylindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;methane;N-[6-methoxy-3-methyl-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(2-cyclohexyl-6-methoxyindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;N-(2-cyclohexyl-6-methoxy-3-methylindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;methane;N-[6-methoxy-3-methyl-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The IUPAC name of N-(2-cyclohexyl-6-methoxyindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;N-(2-cyclohexyl-6-methoxy-3-methylindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;methane;N-[6-methoxy-3-methyl-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (CID 159082886) is N-(2-cyclohexyl-6-methoxyindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;N-(2-cyclohexyl-6-methoxy-3-methylindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;methane;N-[6-methoxy-3-methyl-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.
What is the SMILES notation for N-(2-cyclohexyl-6-methoxyindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;N-(2-cyclohexyl-6-methoxy-3-methylindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;methane;N-[6-methoxy-3-methyl-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The canonical SMILES for N-(2-cyclohexyl-6-methoxyindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;N-(2-cyclohexyl-6-methoxy-3-methylindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;methane;N-[6-methoxy-3-methyl-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is C.COc1cc2nn(C3CCCCC3)c(C)c2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCCCC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCN(C)CC3)c(C)c2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCN(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)c1.COc1cc2nn(C3CCN(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.
What is the InChIKey of N-(2-cyclohexyl-6-methoxyindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;N-(2-cyclohexyl-6-methoxy-3-methylindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;methane;N-[6-methoxy-3-methyl-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The InChIKey is KBBPXUYLZLEAGT-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H24F3N5O2.2C22H23F3N4O2.C21H22F3N5O2.C21H21F3N4O2.CH4/c1-13-15-11-18(27-21(31)16-5-4-6-20(26-16)22(23,24)25)19(32-3)12-17(15)28-30(13)14-7-9-29(2)10-8-14;1-28-8-6-17(7-9-28)29-13-15-11-19(20(31-2)12-18(15)27-29)26-21(30)14-4-3-5-16(10-14)22(23,24)25;1-13-15-11-18(27-21(30)16-9-6-10-20(26-16)22(23,24)25)19(31-2)12-17(15)28-29(13)14-7-4-3-5-8-14;1-28-8-6-14(7-9-28)29-12-13-10-17(18(31-2)11-16(13)27-29)26-20(30)15-4-3-5-19(25-15)21(22,23)24;1-30-18-11-16-13(12-28(27-16)14-6-3-2-4-7-14)10-17(18)26-20(29)15-8-5-9-19(25-15)21(22,23)24;/h4-6,11-12,14H,7-10H2,1-3H3,(H,27,31);3-5,10-13,17H,6-9H2,1-2H3,(H,26,30);6,9-12,14H,3-5,7-8H2,1-2H3,(H,27,30);3-5,10-12,14H,6-9H2,1-2H3,(H,26,30);5,8-12,14H,2-4,6-7H2,1H3,(H,26,29);1H4.
What are the key properties of N-(2-cyclohexyl-6-methoxyindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;N-(2-cyclohexyl-6-methoxy-3-methylindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;methane;N-[6-methoxy-3-methyl-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
N-(2-cyclohexyl-6-methoxyindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;N-(2-cyclohexyl-6-methoxy-3-methylindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;methane;N-[6-methoxy-3-methyl-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide has a molecular weight of 2180.25 g/mol, XLogP of 24.22, 20 rotatable bonds, 5 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for N-(2-cyclohexyl-6-methoxyindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;N-(2-cyclohexyl-6-methoxy-3-methylindazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;methane;N-[6-methoxy-3-methyl-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-methoxy-2-(1-methylpiperidin-4-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is sourced from PubChem (CID 159082886), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).